PAR-25-064-Full-Announcement.html

This document is a Funding Opportunity Announcement (FOA) for the "Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)" grant opportunity.

The goal of this FOA is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD). The findings are expected to advance mechanistic understanding of both biobehavioral and neurobiological pathways leading to NPS, and may provide insight into novel therapeutic targets.

This grant opportunity is funded by the Department of Health and Human Services National Institutes of Health, and falls under the Mental Health Research Grants (CFDA 93.242) and Aging Research (CFDA 93.866) programs. Eligible applicant types include independent school districts, higher education institutions, small businesses, nonprofits, and state/local governments. The funding mechanism is a grant, and the application deadline and award dates are not specified.